Sirio Pharma announcement, to meet the needs of the company's overseas business development, improve the global supply chain system, mitigate global supply chain risks, enhance the company's global competitiveness, the company intends to use its own funds and self-raised funds totaling not more than 40 million US dollars (approximately RMB 0.28994 billion) to invest in building a production base in Thailand. The project company plans to purchase land, build factories and facilities, purchase machinery and equipment, etc.